Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GLOBUS MEDICAL INC Director's Dealing 2012

Aug 10, 2012

30771_dirs_2012-08-10_29871aed-6b9a-4200-af4c-78d5cf97cd2c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GLOBUS MEDICAL INC (GMED)
CIK: 0001237831
Period of Report: 2012-08-08

Reporting Person: WHEELER KURT (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-08 Class A Common Stock C 7444168 $0.00 Acquired 8048433 Indirect
2012-08-08 Class A Common Stock S 804232 $11.16 Disposed 7244201 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-08 Series E Preferred Stock $ C 7444168 Disposed Class A Common Stock (7444168) Indirect

Footnotes

F1: The Company's Series E Preferred Stock automatically converted into the Company's Class A Common Stock on a one-for-one basis upon the closing of the Company's initial public offering and had no expiration date.

F2: Clarus Ventures I Management, L.P. ("Clarus I Management") is the sole general partner of Clarus Lifesciences I, L.P. and Clarus Ventures I, LLC ("Clarus I GPLLC") is the sole general partner of Clarus I Management. Mr. Wheeler is a managing director of Clarus I GPLLC. As a managing director of Clarus I GPLLC, Mr. Wheeler has shared voting and disposition power related to these shares and disclaims beneficial ownership of these shares.